Defining the human gallbladder proteome by transcriptomics and affinity proteomics

Proteomics

Volumn 14, Issue 21-22, 2014, Pages 2498-2507

  Kampf, Caroline ^a   Mardinoglu, Adil ^b   Fagerberg, Linn ^c   Hallström, Björn M ^c   Danielsson, Angelika ^a   Nielsen, Jens ^b,c   Pontén, Fredrik ^a   Uhlen, Mathias ^c,d  

^a UPPSALA UNIVERSITY   (Sweden)

^b CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

^c ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

^d ALBANOVA UNIVERSITY CENTER   (Sweden)

Author keywords

Gallbladder; Proteome; RNA sequencing; Systems biology; Transcriptome

Indexed keywords

GALLBLADDER PROTEOME; PROTEIN ANTIBODY; PROTEOME; UNCLASSIFIED DRUG; TRANSCRIPTOME;

ANTIBODY SPECIFICITY; ARTICLE; CELLS BY BODY ANATOMY; CELLULAR DISTRIBUTION; CLASSIFICATION; CONTROLLED STUDY; GALLBLADDER; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; GENETIC TRANSCRIPTION; GENOME ANALYSIS; HUMAN; HUMAN GENOME; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; METABOLISM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEOMICS; RNA SEQUENCE; TISSUE SECTION; TRANSCRIPTOMICS; CHEMISTRY; GENE EXPRESSION PROFILING; GENETICS; PROCEDURES; SYSTEMS BIOLOGY; ULTRASTRUCTURE;

GALLBLADDER; GENE EXPRESSION PROFILING; HUMANS; PROTEOME; PROTEOMICS; SYSTEMS BIOLOGY; TRANSCRIPTOME;

EID: 84908886781     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201400201     Document Type: Article

References (39)

1. Uhlen, M., Bjorling, E., Agaton, C., Szigyarto, C. A. et al., A human protein atlas for normal and cancer tissues based on antibody proteomics. Mol. Cell Proteomics 2005, 4, 1920-1932.
2. Uhlen, M., Oksvold, P., Fagerberg, L., Lundberg, E. et al., Towards a knowledge-based Human Protein Atlas. Nat. Biotechnol. 2010, 28, 1248-1250.
3. Anderson, L., Seilhamer, J., A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 1997, 18, 533-537.
4. Fagerberg, L., Hallstrom, B. M., Oksvold, P., Kampf, C. et al., Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol. Cell Proteomics 2014, 13, 397-406.
5. Stadler, C., Fagerberg, L., Sivertsson, A., Oksvold, P. et al., RNA- and antibody-based profiling of the human proteome with focus on chromosome 19. J. Proteome Res. 2014, 13, 2019-2027.
6. Danielsson, F., Wiking, M., Mahdessian, D., Skogs, M. et al., RNA deep sequencing as a tool for selection of cell lines for systematic subcellular localization of all human proteins. J. Proteome Res. 2013, 12, 299-307.
7. Apweiler, R., Martin, M. J., O'Donovan, C., Magrane, M. et al., Ongoing and future developments at the Universal Protein Resource. Nucleic Acids Res. 2011, 39, D214-D219.
8. Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D. et al., Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 2000, 25, 25-29.
9. Kanehisa, M., Goto, S., Furumichi, M., Tanabe, M., Hirakawa, M., KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res. 2010, 38, D355-D360.
10. Mardinoglu, A., Agren, R., Kampf, C., Asplund, A. et al., Genome-scale metabolic modelling of hepatocytes reveals serine deficiency in patients with non-alcoholic fatty liver disease. Nat. Commun. 2014, 5, 3083.
11. R Core Team, R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria 2013. Available at http://www.R-project.org/.
12. Shannon, P., Markiel, A., Ozier, O., Baliga, N. S. et al., Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003, 13, 2498-2504.
13. Kampf, C., Olsson, I., Ryberg, U., Sjöstedt, E., Pontén, F., Production of tissue microarrays, immunohistochemistry staining and digitalization within the human protein atlas. J. Vis. Exp. 2012, 63, e3620.
14. Kampf, C., Andersson, A. C., Wester, K., Björling, E. et al., Antibody-based tissue profiling as a tool for clinical proteomics. Clin. Proteomics 2004, 1, 285-299.
15. Agren, R., Bordel, S., Mardinoglu, A., Pornputtapong, N. et al., Reconstruction of genome-scale active metabolic networks for 69 human cell types and 16 cancer types using INIT. Plos Comput. Biol. 2012, 8, e1002518.
16. Mardinoglu, A., Agren, R., Kampf, C., Asplund, A. et al., Integration of clinical data with a genome-scale metabolic model of the human adipocyte. Mol. Syst. Biol. 2013, 9, 649.
17. Agren, R., Mardinoglu, A., Asplund, A., Kampf, C. et al., Identification of anticancer drugs for hepatocellular carcinoma through personalized genome-scale metabolic modeling. Mol. Syst. Biol. 2014, 10, 721.
18. Trapnell, C., Williams, B. A., Pertea, G., Mortazavi, A. et al., Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat. Biotechnol. 2010, 28, 511-515.
19. Hebenstreit, D., Fang, M., Gu, M., Charoensawan, V. et al., RNA sequencing reveals two major classes of gene expression levels in metazoan cells. Mol. Syst. Biol. 2011, 7, 497.
20. Huang, D. W., Sherman, B. T., Lempicki, R. A., Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009, 4, 44-57.
21. Kampf, C., Mardinoglu, A., Fagerberg, L., Hallström, B. et al., The human liver-specific proteome defined by transcriptomics and antibody-based profiling. Faseb. J. 2014, 28, 2901-2914.
22. Lundberg, E., Uhlen, M., Creation of an antibody-based subcellular protein atlas. Proteomics 2010, 10, 3984-3996.
23. Mardinoglu, A., Gatto, F., Nielsen, J., Genome-scale modeling of human metabolism-a systems biology approach. Biotechnol. J. 2013, 8, 985-996.
24. Varemo, L., Nookaew, I., Nielsen, J., Novel insights into obesity and diabetes through genome-scale metabolic modeling. Front Physiol. 2013, 4, 92.
25. Shoaie, S., Nielsen, J., Elucidating the interactions between the human gut microbiota and its host through metabolic modeling. Front Genet. 2014, 5, 86.
26. Mardinoglu, A., Nielsen, J., Systems medicine and metabolic modelling. J. Intern. Med. 2012, 271, 142-154.
27. Shoaie, S., Karlsson, F., Mardinoglu, A., Nookaew, I. et al., Understanding the interactions between bacteria in the human gut through metabolic modeling. Sci. Rep. 2013, 3, 2532.
28. Lundberg, E., Fagerberg, L., Klevebring, D., Matic, I. et al., Defining the transcriptome and proteome in three functionally different human cell lines. Mol. Syst. Biol. 2010, 6, 450.
29. Nagaraj, N., Wisniewski, J. R., Geiger, T., Cox, J. et al., Deep proteome and transcriptome mapping of a human cancer cell line. Mol. Syst. Biol. 2011, 7, 548.
30. Misra, S., Chaturvedi, A., Misra, N. C., Sharma, I. D., Carcinoma of the gallbladder. Lancet Oncol. 2003, 4, 167-176.
31. Akbani, R., Ng, P. K., Werner, H. M., Shahmoradgoli, M. et al., A pan-cancer proteomic perspective on The Cancer Genome Atlas. Nat. Commun. 2014, 5, 3887.
32. Yuan, Y., Van Allen, E. M., Omberg, L., Wagle, N. et al., Assessing the clinical utility of cancer genomic and proteomic data across tumor types. Nat. Biotechnol. 2014, 32, 644-652.
33. Väremo, L., Nielsen, J., Nookaew, I., Enriching the gene set analysis of genome-wide data by incorporating directionality of gene expression and combining statistical hypotheses and methods. Nucleic Acids Res. 2013, 4, 4378-4391.
34. Li, J., Wu, T., Lu, J., Cao, Y. et al., Immunohistochemical evidence of the prognostic value of hedgehog pathway components in primary gallbladder carcinoma. Surg. Today 2012, 42, 770-775.
35. Powers, C. J., McLeskey, S. W., Wellstein, A., Fibroblast growth factors, their receptors and signaling. Endocr. Relat. Cancer 2000, 7, 165-197.
36. Shin, V. Y., Wu, W. K., Chu, K. M., Wong, H. P. et al., Nicotine induces cyclooxygenase-2 and vascular endothelial growth factor receptor-2 in association with tumor-associated invasion and angiogenesis in gastric cancer. Mol. Cancer Res. 2005, 3, 607-615.
37. Wiedlocha, A., Falnes, P. O., Madshus, I. H., Sandvig, K., Olsnes, S., Dual mode of signal transduction by externally added acidic fibroblast growth factor. Cell 1994, 76, 1039-1051.
38. Du, X. L., Wang, S. Z., Lu, J. G., Cao, Y. Z. et al., Correlation between MMP1-PAR1 axis and clinical outcome of primary gallbladder carcinoma. Jpn. J. Clin.Oncol. 2011, 41, 1086-1093.
39. Kirimlioglu, H., Turkmen, I., Bassullu, N., Dirican, A. et al., The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis. Turk. J. Gastroenterol. 2009, 20, 41-47.